Advanced solid tumours
A Study to Assess Changes in Thinking and Memory in Patients with Solid Tumors Receiving Cancer Treatment and to Evaluate Whether Memantine Can Help Reduce Cognitive Decline
Who can joinAdults
Age18+ years
Kind of studyStudy of how care is given
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Advanced Centre for Treatment, Research and Education in CancerNavi Mumbai, MaharashtraDirections ↗
Registry summary (technical)
A Prospective Study Assessing the Impact of Systemic Therapy on Neurocognitive Function and Role of Memantine in Reduction of Cognitive Decline in Patients with Solid Tumors. - CHEMO-COG
Sponsor: ACTREC, TMC
CTRI/2026/09/116796 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 14 Sep 2026 · read by us 5 Nov 2026